These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 11109694)
1. Preference to have used a medically supervised injecting centre among injecting drug users in Kings Cross, Sydney. van Beek I; Gilmour S Aust N Z J Public Health; 2000 Oct; 24(5):540-2. PubMed ID: 11109694 [TBL] [Abstract][Full Text] [Related]
2. Shooting gallery operation in the context of establishing a medically supervised injecting center: Sydney, Australia. Kimber J; Dolan K J Urban Health; 2007 Mar; 84(2):255-66. PubMed ID: 17273925 [TBL] [Abstract][Full Text] [Related]
3. Five years on: what are the community perceptions of drug-related public amenity following the establishment of the Sydney Medically Supervised Injecting Centre? Salmon AM; Thein HH; Kimber J; Kaldor JM; Maher L Int J Drug Policy; 2007 Jan; 18(1):46-53. PubMed ID: 17689343 [TBL] [Abstract][Full Text] [Related]
4. The impact of the Sydney Medically Supervised Injecting Centre (MSIC) on crime. Freeman K; Jones CG; Weatherburn DJ; Rutter S; Spooner CJ; Donnelly N Drug Alcohol Rev; 2005 Mar; 24(2):173-84. PubMed ID: 16076587 [TBL] [Abstract][Full Text] [Related]
5. Estimating the size and dynamics of an injecting drug user population and implications for health service coverage: comparison of indirect prevalence estimation methods. Kimber J; Hickman M; Degenhardt L; Coulson T; van Beek I Addiction; 2008 Oct; 103(10):1604-13. PubMed ID: 18638037 [TBL] [Abstract][Full Text] [Related]
6. High HIV testing and low HIV prevalence among injecting drug users attending the Sydney Medically Supervised Injecting Centre. Salmon AM; van Beek I; Amin J; Grulich A; Maher L Aust N Z J Public Health; 2009 Jun; 33(3):280-3. PubMed ID: 19630850 [TBL] [Abstract][Full Text] [Related]
7. Process and predictors of drug treatment referral and referral uptake at the Sydney Medically Supervised Injecting Centre. Kimber J; Mattick RP; Kaldor J; van Beek I; Gilmour S; Rance JA Drug Alcohol Rev; 2008 Nov; 27(6):602-12. PubMed ID: 19378444 [TBL] [Abstract][Full Text] [Related]
8. Mental health among clients of the Sydney Medically Supervised Injecting Centre (MSIC). Goodhew M; Salmon AM; Marel C; Mills KL; Jauncey M Harm Reduct J; 2016 Oct; 13(1):29. PubMed ID: 27733167 [TBL] [Abstract][Full Text] [Related]
9. The impact of a supervised injecting facility on ambulance call-outs in Sydney, Australia. Salmon AM; van Beek I; Amin J; Kaldor J; Maher L Addiction; 2010 Apr; 105(4):676-83. PubMed ID: 20148794 [TBL] [Abstract][Full Text] [Related]
10. The Sydney Medically Supervised Injecting Centre: a controversial public health measure. Kelly C; Conigrave KM Aust N Z J Public Health; 2002 Dec; 26(6):552-4. PubMed ID: 12530800 [TBL] [Abstract][Full Text] [Related]
11. Injecting-related injury and disease among clients of a supervised injecting facility. Salmon AM; Dwyer R; Jauncey M; van Beek I; Topp L; Maher L Drug Alcohol Depend; 2009 Apr; 101(1-2):132-6. PubMed ID: 19167171 [TBL] [Abstract][Full Text] [Related]
12. Patterns of drug use and associated harms among rural injecting drug users: comparisons with metropolitan injecting drug users. Day C; Conroy E; Lowe J; Page J; Dolan K Aust J Rural Health; 2006 Jun; 14(3):120-5. PubMed ID: 16706881 [TBL] [Abstract][Full Text] [Related]
13. A snapshot of injecting drug consumption from the analysis of used syringes within the Medically Supervised Injecting Centre in Sydney, Australia. Fursman H; Finch E; Xiao L; Lefrançois E; Gupta A; Bartlett M; Latimer J; Chadwick S; Roux C; Morelato M Drug Alcohol Rev; 2024 Mar; 43(3):787-798. PubMed ID: 38145366 [TBL] [Abstract][Full Text] [Related]
14. Performance and image enhancing drug injectors' access to needle syringe programs: Responding to a public policy dilemma. van Beek I; Chronister KJ Int J Drug Policy; 2015 Sep; 26(9):868-74. PubMed ID: 26118797 [TBL] [Abstract][Full Text] [Related]
15. Perceived discrimination and injecting risk among people who inject drugs attending Needle and Syringe Programmes in Sydney, Australia. Wilson H; Brener L; Mao L; Treloar C Drug Alcohol Depend; 2014 Nov; 144():274-8. PubMed ID: 25236889 [TBL] [Abstract][Full Text] [Related]
16. The introduction of a potentially abuse deterrent oxycodone formulation: Early findings from the Australian National Opioid Medications Abuse Deterrence (NOMAD) study. Degenhardt L; Bruno R; Ali R; Lintzeris N; Farrell M; Larance B Drug Alcohol Depend; 2015 Jun; 151():56-67. PubMed ID: 25910850 [TBL] [Abstract][Full Text] [Related]
17. Client satisfaction and risk behaviours of the users of syringe dispensing machines: a pilot study. Islam M; Stern T; Conigrave KM; Wodak A Drug Alcohol Rev; 2008 Jan; 27(1):13-9. PubMed ID: 18034377 [TBL] [Abstract][Full Text] [Related]
18. Frequency and severity of non-fatal opioid overdoses among clients attending the Sydney Medically Supervised Injecting Centre. Roxburgh A; Darke S; Salmon AM; Dobbins T; Jauncey M Drug Alcohol Depend; 2017 Jul; 176():126-132. PubMed ID: 28535454 [TBL] [Abstract][Full Text] [Related]
19. Improving assessment and management of suicide risk among people who inject drugs: A mixed methods study conducted at the Medically Supervised Injecting Centre, Sydney. Hocknull K; Geiger B; Bartlett M; Colledge-Frisby S; Shand F; Day CA; Jauncey M; Roxburgh A Drug Alcohol Rev; 2024 Sep; 43(6):1597-1606. PubMed ID: 38982725 [TBL] [Abstract][Full Text] [Related]
20. Risk factors for hepatitis C virus infection among injecting drug users in Sydney. van Beek I; Buckley R; Stewart M; MacDonald M; Kaldor J Genitourin Med; 1994 Oct; 70(5):321-4. PubMed ID: 8001943 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]